Novo CEO pressed by Senate to cut charges of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the company would look at new talks with insurers with regards to the record charges of Wegovy and copyright if they pledge to help keep the medicines on their https://ayahealthcareaddress72726.imblogs.net/80414718/not-known-facts-about-healthcare-news